Processing your request

please wait...

Case Page


Case Status:    DISMISSED    
On or around 11/30/2016 (Court's order of dismissal)

Filing Date: February 24, 2016

According to the law firm press release, Jarden is a global consumer products company that offers a portfolio of over 120 brands sold through a variety of distribution channels, including club, department store, drug, grocery, mass merchant, sporting goods, and specialty retailers, as well as directly to consumers.

On December 14, 2015, Newell and Jarden announced that the Board had agreed to enter into an Agreement and Plan of Merger pursuant to which: (i) Merger Sub 1 will be merged with and into Jarden, with Jarden surviving as a wholly-owned subsidiary of Newell; and (ii) immediately thereafter, Jarden will be merged with and into Merger Sub 2, with Merger Sub 2 continuing as a wholly-owned subsidiary of Newell (the "Combined Company") following the close of the transaction. On the day the Proposed Acquisition was announced, the consideration to be received by Jarden stockholders had a nominal value of $60.03 per share, consisting of $21 in cash and a fixed exchange ratio of 0.862 shares of Newell common stock.

On January 13, 2016, defendants filed a Registration Statement on Form S-4 with the SEC. On February 17, 2016, defendants filed Amendment No. 1 to that Registration Statement (hereafter, the "Proxy"). The complaint alleges that in contravention of ยงยง14(a) and 20(a) of the 1934 Act, the Proxy, which recommends that Jarden stockholders vote in favor of the Proposed Acquisition, omits and/or misrepresents material information concerning: (i) the Company's flawed and self-serving sales process; (ii) the free cash flow projections provided by Jarden's management and relied on by Barclays Capital Inc. ("Barclays") and Centerview Partners LLC in performing their discounted cash flow valuation analyses; (iii) Barclays' and UBS Securities LLC's conflicts of interest; (iv) Jarden's contributions to the Combined Company; and (v) the Board's consideration of Jarden's standalone value. The misrepresented and/or omitted information is material to shareholders' decision on whether to vote in favor of the Proposed Acquisition.

This case was voluntarily dismissed on November 28, 2016.


Sector: Consumer Non-Cyclical
Industry: Personal & Household Products
Headquarters: United States


Ticker Symbol: JAH
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: S.D. Florida
DOCKET #: 16-CV-80258
JUDGE: Hon. Donald M. Middlebrooks
DATE FILED: 02/24/2016
CLASS PERIOD END: 02/24/2016
  1. Robbins Geller Rudman & Dowd LLP (Boca Raton)
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available